SANUWAVE Health, Inc. (SNWV) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US80303D3052

Price
1.58 USD
Market cap
13.59 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

SANUWAVE Health, Inc. financials

Fiscal year2025
Revenue44.05 m USD
Gross profit33.97 m USD
Operating income4.95 m USD
EBIT11.90 m USD
Net income11.81 m USD
Diluted EPS – continuing operations0.41 USD

Full history since 2006, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About SANUWAVE Health, Inc.

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.